Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1991 May;46(5):372–377. doi: 10.1136/thx.46.5.372

Effects of inhaled budesonide on spirometric values, reversibility, airway responsiveness, and cough threshold in smokers with chronic obstructive lung disease.

B Auffarth 1, D S Postma 1, J G de Monchy 1, T W van der Mark 1, M Boorsma 1, G H Koëter 1
PMCID: PMC1020969  PMID: 2068695

Abstract

Inhaled corticosteroids are known to reduce respiratory symptoms and airway responsiveness in allergic patients with asthma. The aim of the present randomised, double blind study was to assess the effect of eight weeks' treatment with inhaled budesonide in non-allergic smokers with chronic obstructive lung disease. Twenty four subjects (23 male) entered the study. Their ages ranged from 40 to 70 (mean 57) years, with a mean of 35 (range 9-80) pack years of smoking; the mean FEV1 was 53% (range 32-74%) predicted and geometric mean PC20 (histamine concentration causing a 20% fall in FEV1) 0.96 (range 0.07-7.82) mg/ml. After a two week washout, single blind, placebo period, 12 patients were allocated to treatment with budesonide 1600 microgram/day and 12 to placebo for eight weeks. The only additional drug to be taken was ipratropium bromide "if needed." Twenty one patients completed the study, 10 in the budesonide group and 11 in the placebo group. The standard deviation of the difference between duplicate measurements of PC20 histamine and citric acid cough threshold made two weeks apart was below one doubling dose step. There was a significant reduction in dyspnoea in the budesonide group, but otherwise no change in symptom scores or use of ipratropium bromide over the eight weeks of treatment within or between the two groups. No significant differences in spirometric values, peak expiratory flow, PC20 histamine, or citric acid cough threshold were found between the groups. Although differences were not significant, some of the changes showed a trend in favour of budesonide. Whether a longer observation period would show a significant influence of inhaled corticosteroids in patients with chronic obstructive lung disease remains to be determined.

Full text

PDF
372

Images in this article

375Image
on p.375

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BICKERMAN H. A., BARACH A. L. The experimental production of cough in human subjects induced by citric acid aerosols; preliminary studies on the evaluation of antitussive agents. Am J Med Sci. 1954 Aug;228(2):156–163. doi: 10.1097/00000441-195408000-00005. [DOI] [PubMed] [Google Scholar]
  2. Belcher N., Rees P. J. Effects of pholcodine and salbutamol on citric acid induced cough in normal subjects. Thorax. 1986 Jan;41(1):74–75. doi: 10.1136/thx.41.1.74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cox I. D., Wallis P. J., Apps M. C., Hughes D. T., Empey D. W., Osman R. C., Burke C. A. An electromyographic method of objectively assessing cough intensity and use of the method to assess effects of codeine on the dose-response curve to citric acid. Br J Clin Pharmacol. 1984 Sep;18(3):377–382. doi: 10.1111/j.1365-2125.1984.tb02479.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. De Monchy J. G., Kauffman H. F., Venge P., Koëter G. H., Jansen H. M., Sluiter H. J., De Vries K. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis. 1985 Mar;131(3):373–376. doi: 10.1164/arrd.1985.131.3.373. [DOI] [PubMed] [Google Scholar]
  5. Ebden P., Jenkins A., Houston G., Davies B. H. Comparison of two high dose corticosteroid aerosol treatments, beclomethasone dipropionate (1500 micrograms/day) and budesonide (1600 micrograms/day), for chronic asthma. Thorax. 1986 Nov;41(11):869–874. doi: 10.1136/thx.41.11.869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Engel T., Heinig J. H., Madsen O., Hansen M., Weeke E. R. A trial of inhaled budesonide on airway responsiveness in smokers with chronic bronchitis. Eur Respir J. 1989 Nov;2(10):935–939. [PubMed] [Google Scholar]
  7. Gaddie J., Petrie G. R., Reid I. W., Skinner C., Sinclair D. J., Palmer K. N. Aerosol beclomethasone dipropionate: a dose-response study in chronic bronchial asthma. Lancet. 1973 Aug 11;2(7824):280–281. doi: 10.1016/s0140-6736(73)90788-5. [DOI] [PubMed] [Google Scholar]
  8. Harding S. M., Freedman S. A comparison of oral and inhaled steroids in patients with chronic airways obstruction: features determining response. Thorax. 1978 Apr;33(2):214–218. doi: 10.1136/thx.33.2.214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Jenkins C. R., Woolcock A. J. Effect of prednisone and beclomethasone dipropionate on airway responsiveness in asthma: a comparative study. Thorax. 1988 May;43(5):378–384. doi: 10.1136/thx.43.5.378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kerrebijn K. F., van Essen-Zandvliet E. E., Neijens H. J. Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma. J Allergy Clin Immunol. 1987 Apr;79(4):653–659. doi: 10.1016/s0091-6749(87)80163-x. [DOI] [PubMed] [Google Scholar]
  11. Kraan J., Koëter G. H., vd Mark T. W., Sluiter H. J., de Vries K. Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline. J Allergy Clin Immunol. 1985 Oct;76(4):628–636. doi: 10.1016/0091-6749(85)90786-9. [DOI] [PubMed] [Google Scholar]
  12. Lim T. K., Taylor R. G., Watson A., Joyce H., Pride N. B. Changes in bronchial responsiveness to inhaled histamine over four years in middle aged male smokers and ex-smokers. Thorax. 1988 Aug;43(8):599–604. doi: 10.1136/thx.43.8.599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lundgren R., Söderberg M., Hörstedt P., Stenling R. Morphological studies of bronchial mucosal biopsies from asthmatics before and after ten years of treatment with inhaled steroids. Eur Respir J. 1988 Dec;1(10):883–889. [PubMed] [Google Scholar]
  14. Mendella L. A., Manfreda J., Warren C. P., Anthonisen N. R. Steroid response in stable chronic obstructive pulmonary disease. Ann Intern Med. 1982 Jan;96(1):17–21. doi: 10.7326/0003-4819-96-1-17. [DOI] [PubMed] [Google Scholar]
  15. Mitchell D. M., Gildeh P., Rehahn M., Dimond A. H., Collins J. V. Effects of prednisolone in chronic airflow limitation. Lancet. 1984 Jul 28;2(8396):193–196. doi: 10.1016/s0140-6736(84)90481-1. [DOI] [PubMed] [Google Scholar]
  16. Mullen J. B., Wiggs B. R., Wright J. L., Hogg J. C., Paré P. D. Nonspecific airway reactivity in cigarette smokers. Relationship to airway pathology and baseline lung function. Am Rev Respir Dis. 1986 Jan;133(1):120–125. doi: 10.1164/arrd.1986.133.1.120. [DOI] [PubMed] [Google Scholar]
  17. Postma D. S., Peters I., Steenhuis E. J., Sluiter H. J. Moderately severe chronic airflow obstruction. Can corticosteroids slow down obstruction? Eur Respir J. 1988 Jan;1(1):22–26. [PubMed] [Google Scholar]
  18. Postma D. S., Steenhuis E. J., van der Weele L. T., Sluiter H. J. Severe chronic airflow obstruction: can corticosteroids slow down progression? Eur J Respir Dis. 1985 Jul;67(1):56–64. [PubMed] [Google Scholar]
  19. Pounsford J. C., Birch M. J., Saunders K. B. Effect of bronchodilators on the cough response to inhaled citric acid in normal and asthmatic subjects. Thorax. 1985 Sep;40(9):662–667. doi: 10.1136/thx.40.9.662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Pride N. B., Taylor R. G., Lim T. K., Joyce H., Watson A. Bronchial hyperresponsiveness as a risk factor for progressive airflow obstruction in smokers. Bull Eur Physiopathol Respir. 1987 Jul-Aug;23(4):369–375. [PubMed] [Google Scholar]
  21. Rees P. J., Clark T. J. Assessment of antitussive effects by citric acid threshold. Br J Dis Chest. 1983 Jan;77(1):94–97. [PubMed] [Google Scholar]
  22. Reynolds H. Y., Newball H. H. Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage. J Lab Clin Med. 1974 Oct;84(4):559–573. [PubMed] [Google Scholar]
  23. Ryan G., Latimer K. M., Juniper E. F., Roberts R. S., Hargreave F. E. Effect of beclomethasone dipropionate on bronchial responsiveness to histamine in controlled nonsteroid-dependent asthma. J Allergy Clin Immunol. 1985 Jan;75(1 Pt 1):25–30. doi: 10.1016/0091-6749(85)90007-7. [DOI] [PubMed] [Google Scholar]
  24. Shim C., Stover D. E., Williams M. H., Jr Response to corticosteroids in chronic bronchitis. J Allergy Clin Immunol. 1978 Dec;62(6):363–367. doi: 10.1016/0091-6749(78)90137-9. [DOI] [PubMed] [Google Scholar]
  25. Stokes T. C., Shaylor J. M., O'Reilly J. F., Harrison B. D. Assessment of steroid responsiveness in patients with chronic airflow obstruction. Lancet. 1982 Aug 14;2(8294):345–348. doi: 10.1016/s0140-6736(82)90545-1. [DOI] [PubMed] [Google Scholar]
  26. Taylor R. G., Gross E., Joyce H., Holland F., Pride N. B. Smoking, allergy, and the differential white blood cell count. Thorax. 1985 Jan;40(1):17–22. doi: 10.1136/thx.40.1.17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Weir D. C., Gove R. I., Robertson A. S., Burge P. S. Corticosteroid trials in non-asthmatic chronic airflow obstruction: a comparison of oral prednisolone and inhaled beclomethasone dipropionate. Thorax. 1990 Feb;45(2):112–117. doi: 10.1136/thx.45.2.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Yan K., Salome C. M., Woolcock A. J. Prevalence and nature of bronchial hyperresponsiveness in subjects with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1985 Jul;132(1):25–29. doi: 10.1164/arrd.1985.132.1.25. [DOI] [PubMed] [Google Scholar]
  29. de VRIES, GOEI J. T., BOOY-NOORD H., ORIE N. G. Changes during 24 hours in the lung function and histamine hyperreactivity of the bronchial tree in asthmatic and bronchitic patients. Int Arch Allergy Appl Immunol. 1962;20:93–101. doi: 10.1159/000229248. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES